Michael M Mendelson1, Asya Lyass2, Christopher J O'Donnell3, Ralph B D'Agostino2, Daniel Levy4. 1. Framingham Heart Study, Boston University School of Medicine, Boston, Massachusetts 2Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts3Population Studies Branch, Division of Intramural Research, National H. 2. Framingham Heart Study, Boston University School of Medicine, Boston, Massachusetts 4Department of Mathematics and Statistics, Boston University, Boston, Massachusetts. 3. Framingham Heart Study, Boston University School of Medicine, Boston, Massachusetts 5Center for Population Genomics, Veteran's Administration Healthcare System, Boston, Massachusetts6Cardiovascular Epidemiology and Human Genomics Branch, Division of Intra. 4. Framingham Heart Study, Boston University School of Medicine, Boston, Massachusetts 3Population Studies Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Abstract
IMPORTANCE: Dyslipidemia in young adults in the United States during their childbearing years is common, and the consequences for the next generation are poorly understood. Further understanding of the harmful consequences of elevated low-density lipoprotein cholesterol (LDL-C) levels in young adults may help to inform population screening and management strategies. OBJECTIVE: To examine whether adult levels of serum LDL-C are associated with maternal prepregnancy LDL-C levels beyond that attributable to inherited genetic sequence polymorphisms, diet, physical activity, and body mass index. DESIGN, SETTING, AND PARTICIPANTS: The Framingham Heart Study is a multigenerational, population-based inception cohort initiated in 1948 in Framingham, Massachusetts. In this study of families, the analyses included 538 parent-offspring pairs with parental LDL-C levels measured in the study prior to the offspring's birth. Parental prebirth, parental concurrent, and adult offspring assessments occurred in 1971-1983, 1998-2001, and 2002-2005, respectively. Data analyses were conducted between March 1, 2013, and May 30, 2015. EXPOSURES: Maternal prepregnancy LDL-C levels compared with paternal prepregnancy and parental concurrent LDL-C levels in association with adult offspring LDL-C levels. MAIN OUTCOMES AND MEASURES: Adult offspring LDL-C levels were examined as both a continuous and dichotomous outcome (using a threshold of 130 mg/dL). RESULTS: Among the 538 parent-offspring pairs, there were 241 mother-offspring and 297 father-offspring pairs with a mean (SD) offspring age of 26 (3) years. Adult offspring LDL-C levels were associated with maternal prepregnancy LDL-C levels after adjustment for family relatedness and offspring lifestyle, anthropometric factors, and inherited genetic variants (β = 0.32 [SE, 0.05] mg/dL; P < .001). After multivariable adjustment, adults who had been exposed to elevated maternal prepregnancy LDL-C levels were at a 3.8 (95% CI, 1.5-9.8) times higher odds of having elevated LDL-C levels (P = .005) and had an adjusted LDL-C level of 18 mg/dL (95% CI, 9-27 mg/dL) higher than did those without such exposure. Maternal prepregnancy LDL-C levels explained 13% of the variation in adult offspring LDL-C levels beyond common genetic variants and classic risk factors for elevated LDL-C levels. CONCLUSIONS AND RELEVANCE: Adult offspring dyslipidemia is associated with maternal prepregnancy dyslipidemia in excess of measured lifestyle, anthropometric, and inherited genetic factors. The findings support the possibility of a maternal epigenetic contribution to cardiovascular disease risk in the general population. Further research is warranted to determine whether ongoing public health efforts to identify and reduce dyslipidemia in young adults prior to their childbearing years may have additional potential health benefits for the subsequent generation.
IMPORTANCE: Dyslipidemia in young adults in the United States during their childbearing years is common, and the consequences for the next generation are poorly understood. Further understanding of the harmful consequences of elevated low-density lipoprotein cholesterol (LDL-C) levels in young adults may help to inform population screening and management strategies. OBJECTIVE: To examine whether adult levels of serum LDL-C are associated with maternal prepregnancy LDL-C levels beyond that attributable to inherited genetic sequence polymorphisms, diet, physical activity, and body mass index. DESIGN, SETTING, AND PARTICIPANTS: The Framingham Heart Study is a multigenerational, population-based inception cohort initiated in 1948 in Framingham, Massachusetts. In this study of families, the analyses included 538 parent-offspring pairs with parental LDL-C levels measured in the study prior to the offspring's birth. Parental prebirth, parental concurrent, and adult offspring assessments occurred in 1971-1983, 1998-2001, and 2002-2005, respectively. Data analyses were conducted between March 1, 2013, and May 30, 2015. EXPOSURES: Maternal prepregnancy LDL-C levels compared with paternal prepregnancy and parental concurrent LDL-C levels in association with adult offspring LDL-C levels. MAIN OUTCOMES AND MEASURES: Adult offspring LDL-C levels were examined as both a continuous and dichotomous outcome (using a threshold of 130 mg/dL). RESULTS: Among the 538 parent-offspring pairs, there were 241 mother-offspring and 297 father-offspring pairs with a mean (SD) offspring age of 26 (3) years. Adult offspring LDL-C levels were associated with maternal prepregnancy LDL-C levels after adjustment for family relatedness and offspring lifestyle, anthropometric factors, and inherited genetic variants (β = 0.32 [SE, 0.05] mg/dL; P < .001). After multivariable adjustment, adults who had been exposed to elevated maternal prepregnancy LDL-C levels were at a 3.8 (95% CI, 1.5-9.8) times higher odds of having elevated LDL-C levels (P = .005) and had an adjusted LDL-C level of 18 mg/dL (95% CI, 9-27 mg/dL) higher than did those without such exposure. Maternal prepregnancy LDL-C levels explained 13% of the variation in adult offspring LDL-C levels beyond common genetic variants and classic risk factors for elevated LDL-C levels. CONCLUSIONS AND RELEVANCE: Adult offspring dyslipidemia is associated with maternal prepregnancy dyslipidemia in excess of measured lifestyle, anthropometric, and inherited genetic factors. The findings support the possibility of a maternal epigenetic contribution to cardiovascular disease risk in the general population. Further research is warranted to determine whether ongoing public health efforts to identify and reduce dyslipidemia in young adults prior to their childbearing years may have additional potential health benefits for the subsequent generation.
Authors: Claudio Napoli; Filomena de Nigris; John S Welch; Federico B Calara; Robert O Stuart; Christopher K Glass; Wulf Palinski Journal: Circulation Date: 2002-03-19 Impact factor: 29.690
Authors: W Palinski; F P D'Armiento; J L Witztum; F de Nigris; F Casanada; M Condorelli; M Silvestre; C Napoli Journal: Circ Res Date: 2001-11-23 Impact factor: 17.367
Authors: Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy Journal: Am J Epidemiol Date: 2007-03-19 Impact factor: 4.897
Authors: Fanneke E Alkemade; Adriana C Gittenberger-de Groot; Anja E Schiel; J Conny VanMunsteren; Bianca Hogers; Leontien S J van Vliet; Robert E Poelmann; Louis M Havekes; Ko Willems van Dijk; Marco C DeRuiter Journal: Arterioscler Thromb Vasc Biol Date: 2007-07-26 Impact factor: 8.311
Authors: Filomena de Nigris; Francesco Cacciatore; Francesco P Mancini; Dino F Vitale; Gelsomina Mansueto; Francesco P D'Armiento; Concetta Schiano; Andrea Soricelli; Claudio Napoli Journal: JAMA Cardiol Date: 2018-12-01 Impact factor: 14.676
Authors: Jerad H Dumolt; Min Ma; Joyce Mathew; Mulchand S Patel; Todd C Rideout Journal: Am J Physiol Endocrinol Metab Date: 2019-08-27 Impact factor: 4.310
Authors: Linn K L Øyri; Martin P Bogsrud; Jacob J Christensen; Stine M Ulven; Anne Lise Brantsæter; Kjetil Retterstøl; Hilde K Brekke; Trond M Michelsen; Tore Henriksen; Jeanine E Roeters van Lennep; Per Magnus; Marit B Veierød; Kirsten B Holven Journal: BMC Med Date: 2021-04-14 Impact factor: 8.775
Authors: Jyoti Sharma; Jan McAlister; Niti R Aggarwal; Janet Wei; Puja K Mehta; Odayme Quesada; Deirdre Mattina; Nandita S Scott; Erin D Michos; Zainab Mahmoud; Karla Kurrelmeyer; Glaucia Maria Moraes De Oliveira; Kathryn J Lindley Journal: Am J Prev Cardiol Date: 2022-03-13